Table 2
Predicted relative survival ratios (RSR) derived using 2005-2007 life tables and positive bias introduced by using historical life tables to derive expected survival, selected cancers and survival durations, Canada excluding Quebec, 2005 to 2007

Table 2
Predicted relative survival ratios (RSR) derived using 2005-2007 life tables and positive bias introduced by using historical life tables to derive expected survival, selected cancers and survival durations, Canada excluding Quebec, 2005 to 2007
Table summary
This table displays the results of Predicted relative survival ratios (RSR) derived using 2005-2007 life tables and positive bias introduced by using historical life tables to derive expected survival. The information is grouped by Cancer (appearing as row headers), RSR (%) derived using 2005-2007 life tables, Positive absolute bias introduced by using historical life tables (% units), 2000-2002 versus 2005-2007 and 1995-1997 versus 2005-2007 (appearing as column headers).
Cancer RSR (%) derived using 2005-2007 life tables Positive absolute bias introduced by using historical life tables (% units)
2000-2002 versus 2005-2007 1995-1997 versus 2005-2007
1-year 5-year 10-year 1-year 5-year 10-year 1-year 5-year 10-year
All cancers 76.6 62.2 57.2 0.2 0.8 1.7 0.4 1.8 3.7
Oral cavity and pharynx 82.1 61.9 54.0 0.2 0.7 1.4 0.4 1.6 3.1
Esophagus 38.4 14.1 11.0 0.1 0.2 0.4 0.3 0.5 0.8
Stomach 47.4 24.4 22.2 0.2 0.4 0.9 0.4 0.9 1.8
Colon excluding rectum 80.2 62.9 59.3 0.3 1.2 2.4 0.6 2.5 5.3
Rectum and rectosigmoid 85.0 63.3 57.3 0.3 1.0 2.0 0.5 2.2 4.4
Liver 42.0 18.9 15.7 0.1 0.2 0.4 0.2 0.5 0.9
Pancreas 22.6 7.4 6.0 0.1 0.1 0.2 0.1 0.2 0.4
Larynx 84.6 62.6 51.7 0.3 1.0 1.9 0.6 2.3 4.1
Lung and bronchus 39.8 16.2 11.8 0.1 0.2 0.4 0.3 0.5 0.8
Skin melanoma 96.9 88.6 85.1 0.2 1.0 1.8 0.5 2.1 4.0
Female breast 96.9 87.2 80.7 0.1 0.6 1.2 0.3 1.3 2.6
Cervix uteri 88.5 72.8 70.0 0.1 0.2 0.4 0.1 0.4 0.9
Corpus uteri 93.8 85.2 83.7 0.1 0.6 1.3 0.2 1.2 2.9
Ovary 75.3 43.9 36.8 0.1 0.2 0.4 0.2 0.5 0.9
Prostate 98.3 94.9 91.3 0.4 2.0 4.7 0.8 4.3 10.2
Bladder (including in situ) 85.6 70.9 64.7 0.4 1.6 3.0 0.8 3.4 6.6
Kidney and renal pelvis 80.4 67.4 62.4 0.2 0.8 1.7 0.4 1.8 3.6
Brain 46.0 22.6 17.6 0.1 0.1 0.1 0.1 0.2 0.3
Thyroid 98.3 97.7 96.5 0.1 0.3 0.7 0.1 0.7 1.5
Hodgkin lymphoma 91.8 84.8 80.4 0.1 0.2 0.4 0.1 0.5 1.1
Non-Hodgkin lymphoma 78.3 63.8 55.1 0.2 0.7 1.3 0.4 1.6 2.8
Multiple myeloma 73.1 38.0 21.8 0.3 0.6 0.7 0.5 1.3 1.5
Chronic lymphocytic leukemia 92.3 78.8 60.7 0.3 1.4 2.2 0.7 3.0 4.9
Date modified: